Author:
Barman Scott A.,Fulton David
Publisher
Springer International Publishing
Reference76 articles.
1. Prewitt, A. R., Ghose, S., Frump, A. L., et al. (2015). Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension. The Journal of Biological Chemistry, 290, 960–971.
2. Houssaini, A., Abid, S., Mouraret, N., et al. (2013). Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 48, 568–577.
3. Stenmark, K. R., Fagan, K. A., & Frid, M. G. (2006). Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circulation Research, 99, 675–691.
4. Rabinovitch, M., Gamble, W., Nadas, A. S., et al. (1979). Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features. The American Journal of Physiology, 236, H818–H827.
5. Hassoun, P. M., Mouthon, L., Barbera, J. A., et al. (2009). Inflammation, growth factors, and pulmonary vascular remodeling. Journal of the American College of Cardiology, 54, S10–S19.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献